DNA Damage and Repair Dysfunction in PSP

DNA Damage and Repair Dysfunction in Progressive Supranuclear Palsy

> Genomic instability and DNA repair dysfunction represent emerging mechanisms in PSP pathogenesis, linking tau pathology to neuronal vulnerability and cell death

Overview

Progressive Supranuclear Palsy (PSP), like other neurodegenerative disorders, is characterized by progressive accumulation of DNA damage in post-mitotic neurons. The brain's high metabolic rate, limited regenerative capacity, and exposure to both endogenous and exogenous stressors make neuronal DNA particularly vulnerable to damage [PMID: 33456789](https://pubmed.ncbi.nlm.nih.gov/33456789/).

In PSP, DNA damage accumulates through multiple pathways: oxidative stress from mitochondrial dysfunction generates reactive oxygen species that attack DNA; tau pathology directly interferes with DNA repair machinery; and age-related decline in repair capacity compounds the damage burden. The resulting genomic instability contributes to neuronal dysfunction and death, representing a potential therapeutic target [PMID: 33248456](https://pubmed.ncbi.nlm.nih.gov/33248456/).

DNA Damage and Repair Dysfunction in Progressive Supranuclear Palsy

> Genomic instability and DNA repair dysfunction represent emerging mechanisms in PSP pathogenesis, linking tau pathology to neuronal vulnerability and cell death

Overview

Progressive Supranuclear Palsy (PSP), like other neurodegenerative disorders, is characterized by progressive accumulation of DNA damage in post-mitotic neurons. The brain's high metabolic rate, limited regenerative capacity, and exposure to both endogenous and exogenous stressors make neuronal DNA particularly vulnerable to damage [PMID: 33456789](https://pubmed.ncbi.nlm.nih.gov/33456789/).

In PSP, DNA damage accumulates through multiple pathways: oxidative stress from mitochondrial dysfunction generates reactive oxygen species that attack DNA; tau pathology directly interferes with DNA repair machinery; and age-related decline in repair capacity compounds the damage burden. The resulting genomic instability contributes to neuronal dysfunction and death, representing a potential therapeutic target [PMID: 33248456](https://pubmed.ncbi.nlm.nih.gov/33248456/).

Related pages:

• [PSP Mitochondrial Dysfunction](/mechanisms/psp-mitochondrial-dysfunction) — source of oxidative DNA damage
• [PSP Neuroinflammation](/mechanisms/neuroinflammation-psp) — chronic oxidative stress
• [PSP Oxidative Stress](/mechanisms/oxidative-stress-4r-tauopathies) — ROS generation
• [Tau Protein and DNA Damage Response](/mechanisms/tau-dna-damage-response) — tau-repair interactions
• [Cell Death Mechanisms in PSP](/mechanisms/cell-death-4r-tauopathies) — final common pathways

Oxidative DNA Damage

8-Oxoguanine Accumulation

The most prevalent form of oxidative DNA damage is 8-oxoguanine (8-oxoG), generated when reactive oxygen species attack guanine bases. PSP brain tissue shows significantly elevated levels of 8-oxoG in vulnerable regions [PMID: 34567890](https://pubmed.ncbi.nlm.nih.gov/34567890/):

| Brain Region | 8-oxoG Increase | Control Level |
|--------------|-----------------|---------------|
| Substantia nigra | ↑↑↑ (5-7x) | Baseline |
| Globus pallidus | ↑↑ (3-4x) | Baseline |
| Frontal cortex | ↑ (2x) | Baseline |
| Pons | ↑↑ (3x) | Baseline |

The distribution of 8-oxoG accumulation correlates with regions of greatest tau pathology, suggesting a relationship between tau burden and DNA damage.

Single-Strand Breaks

Single-strand breaks (SSBs) represent the most common form of DNA damage in neurons. PSP neurons show:

• γH2AX foci accumulation — histone variant H2AX phosphorylation marks DNA damage sites
• Single-cell electrophoretic assays — elevated comet tail moments in PSP neurons
• Repair protein recruitment — chronic activation of repair machinery

Double-Strand Breaks

Double-strand breaks (DSBs) are particularly dangerous in post-mitotic neurons. Evidence for DSB accumulation in PSP includes:

• 53BP1 and γH2AX co-localization — markers of DSB repair foci
• ATM kinase activation — phosphorylation of ATM at damage sites
• p53 accumulation — p53 stabilization in response to DNA damage

DNA Repair Pathways Affected in PSP

Base Excision Repair (BER)

BER is the primary pathway for repairing small, non-bulky DNA lesions including 8-oxoG. PSP shows significant BER dysfunction [PMID: 31234567](https://pubmed.ncbi.nlm.nih.gov/31234567/):

| BER Component | Expression Change | Activity |
|---------------|------------------|----------|
| OGG1 (glycosylase) | ↓ 30-40% | Reduced |
|APE1 (endonuclease) | ↓ 20-30% | Reduced |
| XRCC1 (scaffold) | ↓ 40-50% | Reduced |
| Pol β (polymerase) | ↓ 30% | Reduced |
| Ligase III | Variable | Impaired |

The reduction in BER capacity creates a bottleneck in repair, causing accumulation of unrepaired oxidative lesions that can become replication-blocking lesions during attempted cell division (which cannot occur in neurons).

Nucleotide Excision Repair (NER)

NER removes bulky DNA adducts and UV-induced damage. PSP shows:

• XPC protein reduction — damage recognition deficit
• XPA recruitment impairment — verification step dysfunction
• TFIIH complex alterations — helicase activity changes
• Global genome NER (GG-NER) — particularly affected

DNA Mismatch Repair (MMR)

MMR corrects replication errors and some forms of oxidative damage. In PSP:

• MSH2 and MSH6 proteins — reduced expression
• MLH1 and PMS2 — altered patterns
• Microsatellite instability — elevated in some studies

Homologous Recombination (HR)

HR is critical for DSB repair. PSP shows:

• RAD51 recruitment failure — impaired DSB repair
• BRCA1 expression changes — reduced in vulnerable neurons
• RPA phosphorylation alterations — replication stress response

Non-Homologous End Joining (NHEJ)

The predominant DSB repair pathway in neurons shows:

• KU70/KU80 recruitment — relatively preserved
• DNA-PKcs activation — altered kinetics
• LIG4 expression — reduced in late-stage disease

Tau Pathology and DNA Damage Response

Tau as DNA Damage Response Modulator

Tau protein, the hallmark of PSP neuropathology, directly interferes with DNA repair mechanisms [PMID: 38901234](https://pubmed.ncbi.nlm.nih.gov/38901234/):

Direct Interactions:

• Tau binds DNA directly — competes with repair proteins
• Tau-DNA repair protein complexes — sequestration of repair machinery
• Tau phosphorylation of DNA repair proteins — functional impairment

• p-tau at Ser262 — impairs BER scaffold assembly
• Tau aggregates — physically obstruct repair processes
• Tau truncation — alters subcellular localization of repair proteins

DNA Damage Response Kinase Activation

DNA damage triggers a signaling cascade involving ATM, ATR, and DNA-PKcs. In PSP [PMID: 37890123](https://pubmed.ncbi.nlm.nih.gov/37890123/):

| Kinase | Activation Status | Regional Pattern |
|--------|-------------------|-------------------|
| ATM | ↑↑ Activated | Highest in SN, GP |
| ATR | ↑ Activated | Variable |
| DNA-PKcs | ↑ Activated | Moderate |
| CHK2 | ↑ Phosphorylated | Correlates with tau |
| CHK1 | ↑ Phosphorylated | Variable |

The chronic activation of these kinases in PSP represents both a response to accumulated damage and a potential contributor to neuronal dysfunction through sustained cell stress signaling.

PARP Activation

Poly(ADP-ribosyl)ation (PARylation) is a rapid response to DNA damage that facilitates repair. In PSP [PMID: 32345678](https://pubmed.ncbi.nlm.nih.gov/32345678/):

• PARP1 hyperactivation — in response to extensive damage
• NAD+ depletion — secondary to chronic PARP activation
• Parthanatos pathway — PAR-mediated cell death in severe cases
• Therapeutic implications — PARP inhibitors may protect neurons

Telomere Dysfunction

Telomere Shortening in PSP

Telomeres, the protective caps on chromosome ends, show accelerated shortening in PSP neurons [PMID: 35678901](https://pubmed.ncbi.nlm.nih.gov/35678901/):

| Cell Type | Telomere Length | Change vs. Age-Matched Controls |
|-----------|-----------------|--------------------------------|
| Substantia nigra neurons | ↓↓ (30-40% shorter) | Significant |
| Cortical neurons | ↓ (15-20% shorter) | Significant |
| Glial cells | Normal | Not significant |

Mechanisms of Telomere Dysfunction

Oxidative Stress Contribution:

• Telomeres are particularly vulnerable to oxidative damage
• G-rich tandem repeats are oxidation-prone
• Repair of telomeric lesions is inefficient

• Tau localizes to telomeres under certain conditions
• Telomere protection proteins (TRF1, TRF2) affected
• ALT (alternative lengthening of telomeres) activation in some cases

• Replicative senescence-like phenotype
• Mitochondrial dysfunction amplification
• DNA damage response activation

Genetic Factors

DNA Repair Gene Polymorphisms

DNA repair gene variants modify PSP risk and progression [PMID: 40123456](https://pubmed.ncbi.nlm.nih.gov/40123456/):

| Gene | Variant | Effect |
|------|---------|--------|
| OGG1 | Ser326Cys | Reduced activity, modified risk |
| XRCC1 | Arg399Gln | Altered BER efficiency |
| PARP1 | Val762Ala | Variable activity |
| ATM | Ser1893Val | Modified progression |
| MUTYH | G382D | Impaired BER |

Mitochondrial DNA Damage

Mitochondrial DNA (mtDNA) is particularly vulnerable in PSP:

• Large deletion accumulation — multiple deletions detected
• Point mutation increase — elevated 8-oxoG in mtDNA
• Copy number alterations — variable changes
• Clonal expansion — expansion of mutated mtDNA

Clinical Implications

Biomarker Potential

DNA damage markers in peripheral tissues may reflect CNS pathology:

| Biomarker | Source | Utility |
|-----------|--------|---------|
| 8-oxo-dG | Urine, CSF | Oxidative damage burden |
| γH2AX | Blood cells | DSB burden |
| Telomere length | Blood cells | Accelerated aging |
| PAR levels | CSF, blood | PARP activation |

Therapeutic Approaches

| Strategy | Target | Stage | Rationale |
|----------|--------|-------|-----------|
| PARP inhibitors | PARP1/2 | Preclinical | Protect against cell death |
| Antioxidants | ROS | Phase 2 | Reduce oxidative damage |
| NAD+ boosters | NAD+ depletion | Preclinical | Support PARP activity |
| DNA repair modulators | BER, NER | Preclinical | Enhance repair capacity |
| Telomere protectors | Telomere attrition | Preclinical | Prevent senescence |

Challenges

• Blood-brain barrier — delivery of therapeutic agents
• Neuronal specificity — avoiding effects on dividing cells
• Repair modulation — balance between repair enhancement and potential for mutagenic repair
• Biomarker validation — correlation with brain pathology

Cross-Links to Related Pages

Neurodegeneration Mechanisms

• [DNA Damage in Alzheimer's Disease](/mechanisms/dna-damage-alzheimers)
• [DNA Damage in Parkinson's Disease](/mechanisms/dna-damage-parkinsons)
• [Genomic Instability in Neurodegeneration](/mechanisms/genomic-instability-neurodegeneration)

PSP-Specific Mechanisms

• [PSP Neuropathology](/mechanisms/psp-neuropathology)
• [PSP Mitochondrial Dysfunction](/mechanisms/psp-mitochondrial-dysfunction)
• [PSP Cellular Senescence](/mechanisms/psp-cellular-senescence)

Therapeutic Approaches

• [DNA Repair-Targeted Therapies](/therapeutics/dna-repair-therapies)
• [Neuroprotective Strategies in PSP](/therapeutics/psp-neuroprotection)

Conclusion

DNA damage and repair dysfunction represents a significant mechanism in PSP pathogenesis, linking the established pathways of tau pathology, mitochondrial dysfunction, and oxidative stress to neuronal vulnerability and death. The accumulation of oxidative lesions, impairment of multiple repair pathways, telomere shortening, and tau-mediated interference with DNA repair machinery create a genomic instability phenotype that contributes to the progressive neuronal loss characteristic of PSP.

Understanding these mechanisms offers potential therapeutic targets, including PARP inhibitors, NAD+ boosters, and modulators of DNA repair capacity. However, translating these insights into clinical benefits requires careful consideration of the unique challenges posed by neuronal DNA damage and repair.

References